検索
Medtronic PLC
MDTウォッチリストに追加
82.350USD
-0.940-1.13%
終値 07/21, 16:00（ET）15分遅れの株価
105.69B時価総額
22.89直近12ヶ月PER
詳細情報 Medtronic PLC 企業名
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Medtronic PLCの企業情報
企業コードMDT
会社名Medtronic PLC
上場日Nov 21, 1977
最高経営責任者「CEO」Martha (Geoffrey S)
従業員数95000
証券種類Ordinary Share
決算期末Nov 21
本社所在地Building Two Parkmore Business Park West
都市DUBLIN
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国Ireland
郵便番号H91 4K49
電話番号1135314381700
ウェブサイトhttps://www.medtronic.com/
企業コードMDT
上場日Nov 21, 1977
最高経営責任者「CEO」Martha (Geoffrey S)
Medtronic PLCの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.95M
-2.15%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
575.08K
+4.68%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
59.78K
-12.50%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.77%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
50.75K
+3.75%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
42.14K
+4.52%
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
23.61K
+8.06%
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Independent Director
Independent Director
19.54K
+9.74%
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Director
Independent Director
10.10K
+18.86%
Ms. Lidia L. Fonseca
Ms. Lidia L. Fonseca
Independent Director
Independent Director
7.63K
+24.97%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.95M
-2.15%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
575.08K
+4.68%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
59.78K
-12.50%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.77%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
50.75K
+3.75%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
42.14K
+4.52%
よくある質問
Medtronic PLCの上位5名の株主は誰ですか？
Medtronic PLCの上位5名の株主は以下のとおりです。Mr. Geoffrey S. (Geoff) Martha
Medtronic PLC（MDT）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Medtronic PLCの株式を保有している機関は3854社あり、保有株式の総市場価値は約1.12Bで、全体の86.90%を占めています。2025Q4と比較して、機関の持ち株は-35115160.00増加しています。
Medtronic PLCの最大の収益源は何ですか？
2026Q1において、Cardiac Rhythm & Heart Failure部門がMedtronic PLCにとって最大の収益を生み出しており、その金額は1.86Bで、全収益の20.58%を占めています。